IntroductionIn critical illness, four measures of glycaemic control are associated with ICU
mortality: mean glucose concentration, glucose variability, the incidence of
hypoglycaemia (≤ 2.2 mmol/l) or low glucose (2.3 to 4.7 mmol/l). Underlying
diabetes mellitus (DM) might affect these associations. Our objective was to study
whether the association between these measures of glycaemic control and ICU
mortality differs between patients without and with DM and to explore the cutoff
value for detrimental low glucose in both cohorts.MethodsThis retrospective database cohort study included patients admitted between
January 2004 and June 2011 to a 24-bed medical/surgical ICU in a teaching
hospital. We analysed glucose and outcome data from 10,320 patients: 8,682 without
DM and 1,638 with DM. The cohorts were subdivided into quintiles of mean glucose
and quartiles of glucose variability. Multivariable regression models were used to
examine the independent association between the four measures of glycaemic control
and ICU mortality, and for defining the cutoff value for detrimental low
glucose.ResultsRegarding mean glucose, a U-shaped relation was observed in the non-DM cohort with
an increased ICU mortality in the lowest and highest glucose quintiles (odds ratio
= 1.4 and 1.8, P < 0.001). No clear pattern was found in the DM
cohort. Glucose variability was related to ICU mortality only in the non-DM
cohort, with highest ICU mortality in the upper variability quartile (odds ratio =
1.7, P < 0.001). Hypoglycaemia was associated with ICU mortality in
both cohorts (odds ratio non-DM = 2.5, P < 0.001; odds ratio DM = 4.2,
P = 0.001), while low-glucose concentrations up to 4.9 mmol/l were
associated with an increased risk of ICU mortality in the non-DM cohort and up to
3.5 mmol/l in the DM cohort.ConclusionMean glucose and high glucose variability are related to ICU mortality in the
non-DM cohort but not in the DM cohort. Hypoglycaemia (≤ 2.2 mmol/l) was
associated with ICU mortality in both. The cutoff value for detrimental low
glucose is higher in the non-DM cohort (4.9 mmol/l) than in the DM cohort (3.5
mmol/l). While hypoglycaemia (≤ 2.2 mmol/l) should be avoided in both
groups, DM patients seem to tolerate a wider glucose range than non-DM
patients.